Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...
SAN FRANCISCO, California — A small, phase 2 study, with a biomarker test for its primary end point, offers some encouraging hints that the P-selectin antagonist inclacumab may be able to reduce ...
Background Emergency Medical Services (EMS) patients with chest pain are often suspected of having non-ST-elevation acute coronary syndrome (NSTE-ACS). Current risk stratification protocols for ...
Acute coronary syndrome (ACS) in younger patients presents distinctive epidemiological and clinical patterns when compared with older cohorts. Although traditionally viewed as a disease of older ...
The American College of Cardiology and the American Heart Association today released an updated clinical practice guideline for managing individuals experiencing acute coronary syndrome (ACS). The ...
PARIS, France—Among patients with acute MI and occlusive disease on invasive angiography, those presenting without ST-segment elevation on the initial ECG fare worse than those with STEMI, researchers ...
For many years, 2 axioms have ruled our thoughts and discussions of coronary atherosclerosis. The first axiom was that patients were at risk for acute coronary syndromes (ACS) if their coronary ...
The diagnostics advisory committee considered evidence on high-sensitivity troponin tests for the early rule out of non-ST-segment elevation myocardial infarction (NSTEMI) from several sources. Full ...
Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback